Abstract
In the last decade, a strategy for targeting antigens to dendritic cells (DCs) in vivo has been developed successfully in animal models. DCs are central cells in the process of inducing immunity against various pathogens and tolerance. Our strategy is to use a monoclonal antibody against a receptor on the surface of DC fused with the antigen of interest. The administration of low doses of…